Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.33 |
| ▸ | PPARD | Q03181 | 1/20 | 0.33 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.33 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.32 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.32 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21409835 | 0.78 | SPHK1 (0.42) | ACE2GPR84CA1FFAR1MAPT | |
| SCHEMBL851799 | 0.77 | SPHK1 (0.32) | CA2 | |
| SCHEMBL1249046 | 0.76 | ALDH1A1 (0.36) | MAPTALDH1A1TSHRFAAH | |
| SCHEMBL7945803 | 0.69 | FFAR1 (0.46) | ACE2GPR84CA1FFAR1MAPT | |
| SCHEMBL3174984 | 0.69 | ACE2 (0.46) | CA2ACE2GPR84CA1FFAR1 | |
| SCHEMBL25280872 | 0.69 | ACE2 (0.46) | CA2ACE2GPR84CA1FFAR1 | |
| SCHEMBL7951710 | 0.69 | FFAR1 (0.46) | ACE2GPR84CA1FFAR1MAPT | |
| SCHEMBL7956331 | 0.69 | FFAR1 (0.46) | ACE2GPR84CA1FFAR1MAPT | |
| SCHEMBL7945817 | 0.69 | FFAR1 (0.46) | ACE2GPR84CA1FFAR1MAPT | |
| SCHEMBL7945800 | 0.69 | FFAR1 (0.46) | ACE2GPR84CA1FFAR1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10420790-B2 | Micellic assemblies | UNIVERSITY OF WASHINGTON (US) | 2019-09-24 | — | — | US | disclosed |
| US-20170239360-A1 | MICELLIC ASSEMBLIES | UNIVERSITY OF WASHINGTON (US) | 2017-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10420790-B2 | Micellic assemblies | UACA, CLPTM1L, BPHL | CA2 352/4885ACE2 822/4885GPR84 3730/4885 |
| US-20170239360-A1 | MICELLIC ASSEMBLIES | UACA, CLPTM1L, BPHL | CA2 352/4885ACE2 822/4885GPR84 3730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.